IDEAYA Biosciences, Inc. (IDYA)
31.67
-0.16
(-0.50%)
USD |
NASDAQ |
Apr 22, 16:00
31.65
-0.02
(-0.06%)
Pre-Market: 08:38
IDEAYA Biosciences Shareholders Equity (Quarterly) : 1.023B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Amgen, Inc. | 8.658B |
| Spyre Therapeutics, Inc. | 715.24M |
| Replimune Group, Inc. | 210.54M |
| Black Diamond Therapeutics, Inc. | 112.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.109B |
| Total Liabilities (Quarterly) | 86.39M |
| Debt to Equity Ratio | 0.0273 |
| Current Ratio | 11.34 |
| Net Debt Paydown Yield | -0.06% |